HIV persistence in lymph nodes.

Détails

Ressource 1Télécharger: HIV persistence in lymph nodes.pdf (466.00 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_5241DE0E66BD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
HIV persistence in lymph nodes.
Périodique
Current opinion in HIV and AIDS
Auteur⸱e⸱s
Banga R., Munoz O., Perreau M.
ISSN
1746-6318 (Electronic)
ISSN-L
1746-630X
Statut éditorial
Publié
Date de publication
01/07/2021
Peer-reviewed
Oui
Volume
16
Numéro
4
Pages
209-214
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish
Résumé
HIV persists in distinct cellular and anatomical compartments in the body including blood, Central nervous system, and lymphoid tissues (spleen, lymph nodes [LNs], gut-associated lymphoid tissue) by diverse mechanisms despite antiretroviral therapy. Within LNs, human and animal studies have highlighted that a specific CD4 T cell subset - called T follicular helper cells locating in B cell follicles is enriched in cells containing replication-competent HIV as compared to extra-follicular CD4 T cells. Therefore, the objective of the present review is to focus on the potential mechanisms allowing HIV to persist within LN microenvironment.
The combination of factors that might be involved in the regulation of HIV persistence within LNs remain to be fully identified but may include - the level of activation, antiretroviral drug concentrations, presence of cytolytic mechanisms and/or regulatory cells, in addition to cell survival and proliferation propensity which would ultimately determine the fate of HIV-infected cells within LN tissue areas.
HIV persistence in blood and distinct body compartments despite long-standing and potent therapy is one of the major barriers to a cure. Given that the HIV reservoir is established early and is highly complex based on composition, viral diversity, distribution, replication competence, migration dynamics across the human body and possible compartmentalization in specific tissues, combinatorial therapeutic approaches are needed that may synergize to target multiple viral reservoirs to achieve a cure for HIV infection.
Mots-clé
Animals, Anti-Retroviral Agents/therapeutic use, CD4-Positive T-Lymphocytes, HIV Infections/drug therapy, HIV-1, Humans, Lymph Nodes, Virus Replication
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/06/2021 13:41
Dernière modification de la notice
16/01/2024 7:18
Données d'usage